Literature DB >> 7664763

Basement membrane status in undifferentiated carcinomas of the ovary. Immunohistochemical distribution of type IV collagen and laminin.

Y Kuwashima1, T Uehara, M Kurosumi, K Kishi, K Shiromizu, M Matsuzawa, S Takayama.   

Abstract

Basement membrane status in well-differentiated and undifferentiated carcinomas of the ovary was examined and compared immunohistochemically by using antibodies which react with type IV collagen and laminin. In well-differentiated carcinomas, which included 8 serous, 8 mucinous, 4 endometrioid and 4 clear cell adenocarcinomas, the staining showed a regular and linear pattern in the interface between epithelium and stroma. However, in 8 cases of undifferentiated carcinoma, the staining for two antibodies was irregular, being either completely negative or focally positive in the portion surrounding the carcinoma cell nests. In some cases, intracytoplasmic staining was observed. Staining patterns for two antibodies were somewhat different within undifferentiated carcinoma cases. It is concluded that in ovarian undifferentiated carcinomas, the architecture of basement membrane is substantially altered compared to their differentiated counterparts.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7664763

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  3 in total

1.  37-kDa laminin receptor precursor mediates GnRH-II-induced MMP-2 expression and invasiveness in ovarian cancer cells.

Authors:  Song Ling Poon; Christian Klausen; Geoffrey L Hammond; Peter C K Leung
Journal:  Mol Endocrinol       Date:  2010-12-30

2.  MMP-2 release and activation in ovarian carcinoma: the role of fibroblasts.

Authors:  R S Boyd; F R Balkwill
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

3.  Establishment of a new representative model of human ovarian cancer in mice.

Authors:  Jianjun Zhang; Xinlian Chen; Gang Shi; Xiaoyan Xie; Hongqian Liu; Xuemei Zhang; Yi Lai; Yan Zuo; Zhong Chen; Shanling Liu; He Wang
Journal:  J Ovarian Res       Date:  2013-02-06       Impact factor: 4.234

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.